Variant report
Variant | esv1827618 |
---|---|
Chromosome Location | chr6:161231592-161246303 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161231600..161233858-chr6:161239225..161241427,2 | K562 | blood: | |
2 | chr6:161235361..161237238-chr6:161238681..161240959,2 | K562 | blood: | |
3 | chr6:161227686..161230343-chr6:161232478..161234190,2 | K562 | blood: | |
4 | chr6:161235361..161237238-chr6:161238681..161240959,2 | K562 | blood: | |
5 | chr6:161227565..161229491-chr6:161229972..161232150,2 | MCF-7 | breast: | |
6 | chr6:161231600..161233858-chr6:161239225..161241427,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LPA-2 | chr6:161237596-161237875 | XLOC_005906 |
2 | lnc-LPA-2 | chr6:161236582-161237293 | XLOC_005906 |
3 | lnc-LPA-2 | chr6:161238186-161238383 | XLOC_005906 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9456592 | chr6:161231592-161231593 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs144602838 | chr6:161231596-161231597 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558487313 | chr6:161231602-161231603 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575353965 | chr6:161231631-161231632 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188211237 | chr6:161231674-161231675 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148203012 | chr6:161231700-161231701 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369345797 | chr6:161231702-161231703 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73784988 | chr6:161231756-161231757 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74798217 | chr6:161231770-161231771 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79693774 | chr6:161231786-161231787 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538288815 | chr6:161231803-161231804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150737979 | chr6:161231804-161231805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564899736 | chr6:161231807-161231808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530500925 | chr6:161231839-161231840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139095347 | chr6:161231862-161231863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567363314 | chr6:161231879-161231880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193255211 | chr6:161231897-161231898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547131509 | chr6:161231994-161231995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184082692 | chr6:161232009-161232010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149604584 | chr6:161232074-161232075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187848493 | chr6:161232152-161232153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191554927 | chr6:161232153-161232154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537848156 | chr6:161232177-161232178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9458040 | chr6:161232224-161232225 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs373680216 | chr6:161232255-161232256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183693784 | chr6:161232256-161232257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559473623 | chr6:161232266-161232267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372556742 | chr6:161232281-161232282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368108134 | chr6:161232370-161232371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147310409 | chr6:161232391-161232392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371087621 | chr6:161232437-161232438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188753644 | chr6:161232456-161232457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530566508 | chr6:161232458-161232459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544178281 | chr6:161232532-161232533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192592161 | chr6:161232575-161232576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529759825 | chr6:161232685-161232686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546900138 | chr6:161232765-161232766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs783157 | chr6:161232771-161232772 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs376818075 | chr6:161232786-161232787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566006478 | chr6:161232798-161232799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532588961 | chr6:161232813-161232814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368202100 | chr6:161232851-161232852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372304365 | chr6:161232868-161232869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185332850 | chr6:161232956-161232957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141022098 | chr6:161232973-161232974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376659888 | chr6:161232976-161232977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534911157 | chr6:161232994-161232995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554511008 | chr6:161233018-161233019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568486032 | chr6:161233038-161233039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534332414 | chr6:161233070-161233071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161231200-161231600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr6:161231200-161231800 | Enhancers | HepG2 | liver |
3 | chr6:161231400-161231800 | Active TSS | A549 | lung |
4 | chr6:161231400-161233000 | Weak transcription | GM12878-XiMat | blood |
5 | chr6:161233000-161233600 | Enhancers | GM12878-XiMat | blood |